References
Teasley, D. G., Gerding, D. N., Olson, M. M., Peterson, L. R., Gebhard, R. L., Schwartz, M. J., Lee, J. T.: Prospective randomized trial of metronidazole versus vancomycin forClostridium difficille-associated diarrhoea and colitis. Lancet 1983, ii: 1043–1046.
O'Keefe, J. P., Troc, K. A., Thompson, K. D.: Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1982, 22: 426–430.
Reed, L. J., Muench, H.: A simple method for estimating fifty percent end points. American Journal of Hygiene 1983, 27: 493–497.
George, W. L., Sutter, V. L., Pinegold, S. M.: Toxigenicity and antimicrobial susceptibility ofClostridium difficile, a cause of antimicrobial-associated colitis. Current Microbiology 1978, 1: 55–58.
Dzink, J., Bartlett, J. G.: In vitro susceptibility ofClostridium difficile isolated from patients with antibiotic-associated diarrhoea or colitis. Antimicrobial Agents and Chemotherapy 1980, 17: 695–698.
Chow, A. W., Cheng, N., Bartlett, K. H.: In vitro susceptibility ofClostridium difficile to newβ-lactam and quinolone antibiotics. Antimicrobial Agents and Chemotherapy 1985, 28: 842–844.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bannatyne, R., Jackowski, J. Susceptibility ofClostridium difficile to metronidazole, its bioactive metabolites and tinidazole. Eur. J, Clin. Microbiol. 6, 505–506 (1987). https://doi.org/10.1007/BF02013130
Issue Date:
DOI: https://doi.org/10.1007/BF02013130